$BBLR
Bubblr Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223027954 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $1.151K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $1.151K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $1.109M $1.285M
YoY Change 1358.73% 2009.12%
% of Gross Profit 96364.81%
Research & Development $59.89K $52.12K
YoY Change 12.72% -1.09%
% of Gross Profit 5203.21%
Depreciation & Amortization $176.8K $3.106K
YoY Change
% of Gross Profit 15364.03%
Operating Expenses $1.237M $1.790M
YoY Change 142.57% -27.91%
Operating Profit -$1.236M -$1.790M
YoY Change 142.35% -27.91%
Interest Expense $7.704K $617.00
YoY Change -92.45% -97.97%
% of Operating Profit
Other Income/Expense, Net $64.90K $86.63K
YoY Change -167.34% -30.06%
Pretax Income -$1.171M -$1.703M
YoY Change 93.13% -27.8%
Income Tax
% Of Pretax Income
Net Earnings -$1.171M -$1.703M
YoY Change 93.13% -27.8%
Net Earnings / Revenue -101755.26%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 157.2M shares 156.3M shares 157.7M shares
Diluted Shares Outstanding 156.1M shares 156.3M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.660K
YoY Change
Cash & Equivalents $1.660K $5.507K $32.53K
Short-Term Investments
Other Short-Term Assets $200.00
YoY Change
Inventory
Prepaid Expenses
Receivables $9.884K
Other Receivables $9.093K $7.741K $9.884K
Total Short-Term Assets $10.75K $13.25K $42.42K
YoY Change -95.31% -90.52% -73.68%
LONG-TERM ASSETS
Property, Plant & Equipment $39.13K $43.87K $47.96K
YoY Change -17.04% -20.0% -31.12%
Goodwill
YoY Change
Intangibles $1.191M $1.284M $31.83K
YoY Change 3989.38% 3947.05% -3.06%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.230M $1.328M $1.374M
YoY Change 6.06% -1.99% -19.02%
TOTAL ASSETS
Total Short-Term Assets $10.75K $13.25K $42.42K
Total Long-Term Assets $1.230M $1.328M $1.374M
Total Assets $1.241M $1.341M $1.416M
YoY Change -10.68% -10.27% -23.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $293.2K $194.0K $141.6K
YoY Change 179.16% 43.24% -29.43%
Accrued Expenses $1.317M $834.4K $50.09K
YoY Change 133.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $826.7K
YoY Change
Total Short-Term Liabilities $2.437M $1.795M $595.9K
YoY Change -15.83% 192.54% -20.0%
LONG-TERM LIABILITIES
Long-Term Debt $532.8K
YoY Change
Other Long-Term Liabilities $83.50K
YoY Change
Total Long-Term Liabilities $616.3K $757.4K $734.2K
YoY Change -21.3% -72.06% -67.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.437M $1.795M $595.9K
Total Long-Term Liabilities $616.3K $757.4K $734.2K
Total Liabilities $3.053M $2.552M $1.330M
YoY Change -16.99% -23.21% -55.45%
SHAREHOLDERS EQUITY
Retained Earnings -$16.07M -$14.88M -$12.88M
YoY Change 29.35% 26.13% 53.54%
Common Stock $1.572M $1.569M $1.543M
YoY Change -0.27% -0.19% 10.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.812M -$1.211M $86.28K
YoY Change
Total Liabilities & Shareholders Equity $1.241M $1.341M $1.416M
YoY Change -10.68% -10.27% -23.76%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$1.171M -$1.703M
YoY Change 93.13% -27.8%
Depreciation, Depletion And Amortization $176.8K $3.106K
YoY Change
Cash From Operating Activities -$412.6K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $21.94K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$21.94K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 383.0K
YoY Change
NET CHANGE
Cash From Operating Activities -412.6K
Cash From Investing Activities -21.94K
Cash From Financing Activities 383.0K
Net Change In Cash -51.57K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$412.6K
Capital Expenditures $21.94K
Free Cash Flow -$434.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-260902
dei Entity Central Index Key
EntityCentralIndexKey
0001873722
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
BBLR Share Based Finance Incentive
ShareBasedFinanceIncentive
usd
BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Payments Of Dividends
PaymentsOfDividends
usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2022Q4 BBLR Director Fees
DirectorFees
usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
dei Entity Registrant Name
EntityRegistrantName
Bubblr, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2355916
dei Entity Address Address Line1
EntityAddressAddressLine1
21 West 46th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
814 7184
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
157201261 shares
CY2023Q2 us-gaap Cash
Cash
5507 usd
CY2022Q4 us-gaap Cash
Cash
32533 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7741 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9884 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
13248 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
42417 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43870 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47956 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1284290 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1325995 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1328160 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1373951 usd
CY2023Q2 us-gaap Assets
Assets
1341408 usd
CY2022Q4 us-gaap Assets
Assets
1416368 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
194036 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
141605 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
834373 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50094 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
12562 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
11987 usd
CY2023Q2 BBLR Loan Payable Related Party Current
LoanPayableRelatedPartyCurrent
753844 usd
CY2022Q4 BBLR Loan Payable Related Party Current
LoanPayableRelatedPartyCurrent
392170 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1794815 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
595856 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
5895 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10465 usd
CY2023Q2 BBLR Loan Payable Related Party Noncurrent
LoanPayableRelatedPartyNoncurrent
550468 usd
CY2022Q4 BBLR Loan Payable Related Party Noncurrent
LoanPayableRelatedPartyNoncurrent
525291 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
201010 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
198479 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
757373 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
734235 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2552188 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1330091 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
156888761 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
156888761 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154309318 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154309318 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1568888 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1543093 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11744313 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11006607 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14876334 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12875437 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
352352 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
412013 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1210780 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
86277 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1341408 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1416368 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1178987 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
188856 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1195276 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
340919 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
390304 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
2095727 usd
us-gaap Professional Fees
ProfessionalFees
164734 usd
us-gaap Professional Fees
ProfessionalFees
2288556 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
105553 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44595 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
418016 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
82188 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
62882 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100859 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
122509 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
208454 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52119 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52694 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91271 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
113955 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1789845 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2482731 usd
us-gaap Operating Expenses
OperatingExpenses
1991806 usd
us-gaap Operating Expenses
OperatingExpenses
3034072 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1789845 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2482731 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1991806 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3034072 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
15 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
402 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
113 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
854 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
617 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
30420 usd
us-gaap Interest Expense
InterestExpense
1746 usd
us-gaap Interest Expense
InterestExpense
445264 usd
CY2023Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
69988 usd
CY2022Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
275178 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2531 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
251287 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17242 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-121307 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
38417 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-162014 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86628 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
123853 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34253 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-355137 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1703217 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2358878 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1957553 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3389209 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1703217 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2358878 usd
us-gaap Net Income Loss
NetIncomeLoss
-1957553 usd
us-gaap Net Income Loss
NetIncomeLoss
-3389209 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40519 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
47306 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-59661 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
60679 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-40519 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
47306 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-59661 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
60679 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1743736 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2311572 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2017214 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3328530 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156260342 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156260342 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141103372 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141103372 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155578988 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155578988 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141124825 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141124825 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1127590 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
75460 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8980 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
379814 usd
CY2022Q1 BBLR Dividend Series C Preferred Stock
DividendSeriesCPreferredStock
-3272 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1030331 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13373 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1683566 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1993081 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
94150 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
95768 usd
CY2022Q2 BBLR Dividend Series C Preferred Stock
DividendSeriesCPreferredStock
-16754 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2358878 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47306 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1828893 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
86277 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
285338 usd
CY2023Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
659052 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
22133 usd
CY2023Q1 BBLR Dividend Series C Preferred Stock
DividendSeriesCPreferredStock
-21672 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-254336 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19142 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-560454 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-560454 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50000 usd
CY2023Q2 BBLR Stock Issued During Period Value Issued For Professional Services
StockIssuedDuringPeriodValueIssuedForProfessionalServices
65000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
21672 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
978410 usd
CY2023Q2 BBLR Dividend Series C Preferred Stock
DividendSeriesCPreferredStock
-21672 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1703217 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40519 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1210780 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1210780 usd
us-gaap Profit Loss
ProfitLoss
-1957553 usd
us-gaap Profit Loss
ProfitLoss
-3389209 usd
us-gaap Share Based Compensation
ShareBasedCompensation
400338 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2077521 usd
BBLR Share Based Finance Incentive
ShareBasedFinanceIncentive
379814 usd
BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
-978410 usd
BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
-94150 usd
BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
-659052 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2531 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
251287 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39856 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116125 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187621 usd
us-gaap Depreciation
Depreciation
6384 usd
us-gaap Depreciation
Depreciation
7826 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2537 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4945 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
711929 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24283 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
114764 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-57572 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-283587 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-882052 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12839 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19228 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12839 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19228 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
3272 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4934 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
26434 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
324973 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19709 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18228 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
77940 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
789000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301811 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
716063 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32411 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178182 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27026 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7035 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32533 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62967 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5507 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
55932 usd
us-gaap Interest Paid Net
InterestPaidNet
5385 usd
us-gaap Interest Paid Net
InterestPaidNet
6332 usd
us-gaap Dividends Common Stock
DividendsCommonStock
43344 usd
us-gaap Dividends Common Stock
DividendsCommonStock
16754 usd
us-gaap Stock Issued1
StockIssued1
43805 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-10-22
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2017214 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14876334 usd
CY2023Q2 BBLR Working Capital
WorkingCapital
1781567 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_z7AK3kNEUe57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zz2BpZNygVC8">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
BBLR Accumulated Depreciation Depletion And Amortization Foreign Currency Translation Adjustments
AccumulatedDepreciationDepletionAndAmortizationForeignCurrencyTranslationAdjustments
1805 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45850 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43870 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47956 usd
us-gaap Depreciation
Depreciation
6384 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
201010 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
198479 usd
us-gaap Depreciation
Depreciation
7826 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_848_eus-gaap--DerivativesReportingOfDerivativeActivity_zKYYMfjpGRNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zmb0lEGdzdb1">Common Stock Purchase Warrants and Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7769363 shares
CY2023Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2681 pure
CY2022Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2174 pure
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2101 pure
CY2023Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2338 pure
CY2022Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2990 pure
CY2022Q4 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2430 pure
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
38417 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
162014 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zHfV9D4ZNgLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zWJ0s71cGWBl">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented.</span></p>
CY2023Q2 us-gaap Deposit Assets
DepositAssets
200 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
200 usd
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
7541 usd
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
9684 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7741 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9884 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
85617 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-0 usd
BBLR Effects Of Foreign Currency Translation Property Equipment
EffectsOfForeignCurrencyTranslationPropertyEquipment
4103 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
89720 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37661 usd
us-gaap Depreciation
Depreciation
6384 usd
CY2023Q2 BBLR Finite Lived Trademarks Effects Of Currency Translation
FiniteLivedTrademarksEffectsOfCurrencyTranslation
-1936 usd
CY2022Q4 BBLR Finite Lived Trademarks Effects Of Currency Translation
FiniteLivedTrademarksEffectsOfCurrencyTranslation
-3461 usd
CY2023Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
34657 usd
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
31826 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3010069 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3010069 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
12839 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
142079 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3164987 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3164987 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1684074 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1684074 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116125 usd
BBLR Finite Lived Intangible Assets Accumulated Amortization Effects Of Currency Translation
FiniteLivedIntangibleAssetsAccumulatedAmortizationEffectsOfCurrencyTranslation
80498 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1880697 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1880697 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1284290 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1325995 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
12839 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
19228 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116125 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187621 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
80261 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
160521 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
160521 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
160521 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
160521 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
160521 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
366767 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1249633 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
59474 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3143 usd
CY2023Q2 BBLR Director Fees
DirectorFees
68750 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
21672 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
22133 usd
CY2023Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
154185 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
530292 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24818 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
834373 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50094 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
12562 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
11987 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
5895 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10465 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4934 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5102 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
7402 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
9868 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
17270 usd
CY2023Q2 BBLR Imputed Interest
ImputedInterest
1187 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
18457 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
12562 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
5895 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
28043 usd
us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
95768 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
156888761 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
156888761 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154309318 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154309318 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2022Q4 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2022 BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2023Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2023Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M7D
CY2023Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2023Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
2538101 shares
CY2023Q2 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
0.32
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0 usd
CY2022 BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
659052 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
1600548 usd
CY2023Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
1600548 usd
CY2023Q2 BBLR Deferred Compensation Equity Reversed
DeferredCompensationEquityReversed
659052 usd
CY2023Q2 BBLR Option Vest Description
OptionVestDescription
Company granted options for the purchase of our Common stock to certain employees and non-employees as consideration for services rendered. The terms of the stock option grants are determined by our Board of Directors consistent with our 2022 Equity Incentive Plan which the Board adopted May 22, 2022. Our stock option grant general policy is options vest 40% on Grant Date, which is 90 days after commencement of service (typically the hire date) and the remaining vest monthly over 2 years and have a maximum term of ten years. Two executives with long term service in excess of 2 years and nine months were 100% vested on Grant Date.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.95 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.97 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0365 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0373 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7680000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7680000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7680000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y9M3D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5832000 shares
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
298840 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
0 usd

Files In Submission

Name View Source Status
bblr-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-027954-index-headers.html Edgar Link pending
0001493152-23-027954-index.html Edgar Link pending
0001493152-23-027954.txt Edgar Link pending
0001493152-23-027954-xbrl.zip Edgar Link pending
bblr-20230630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
form10-q_002.jpg Edgar Link pending
form10-q_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
bblr-20230630_pre.xml Edgar Link unprocessable
bblr-20230630_lab.xml Edgar Link unprocessable
bblr-20230630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending